Gene hunt: could DNA secrets unlock rhabdomyosarcoma prognosis?
NCT ID NCT03296371
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study explores genetic mutations in children with embryonal or alveolar rhabdomyosarcoma by analyzing saliva or cheek cell samples from the child and their parents. The goal is to identify inherited or new gene changes that may help doctors predict how the disease will progress. About 900 participants and their parents are involved, but this research does not test any new treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EMBRYONAL RHABDOMYOSARCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Childrens Oncology Group
Philadelphia, Pennsylvania, 19104, United States